MRKR compared with CSBR: revenue, margins and what each company keeps, and the suppliers and customers both name

MRKRMarker Therapeutics, Inc.

Mkt capRevenueRevenue

CSBRChampions Oncology, Inc.

Mkt capRevenueRevenue

Compare

MRKRMarker Therapeutics, Inc.

CSBRChampions Oncology, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

MRKR

No earnings history for MRKR.

CSBR2 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Sep 11 '26±51.5%▲+0.09%×0.00

Q1 FY27—▼−8.75%—

= impliedMRKR realized, solidCSBR realized, hatchedOne scale, both sides: full bar = 52%× = |realized| ÷ impliedSource: market data

MRKRMarker Therapeutics, Inc.

0.99▲+10.35%

Mkt cap$16.3MRevenue$1MQ4 FY25Revenue$7MFY24

CSBRChampions Oncology, Inc.

4.87▲+1.25%

Regular sessionNov 3 '26

Mkt cap$66.9MRevenue$15MQ1 FY27Revenue$59MFY26

Compare

Regular sessionNov 3 '26

MRKRMarker Therapeutics, Inc.

CSBRChampions Oncology, Inc.

0.99▲+10.35%

Price

4.87▲+1.25%

$16.3M

Mkt cap

$66.9M

Q4 FY25$1M

Revenue

$15MQ1 FY27

FY24$7M

Revenue

$59MFY26

MRKR0.99▲+10.35%vsCSBR4.87▲+1.25%Regular sessionNov 3 '26